Vanguard Fiduciary Trust
NMRA icon

Vanguard Fiduciary Trust’s Neumora Therapeutics NMRA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
706,667
+171,634
+32% +$327K ﹤0.01% 2946
2026
Q1 		$1.04M Buy
+535,033
New +$1.39M ﹤0.01% 2894

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Fiduciary Trust's NMRA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Neumora Therapeutics (NMRA) stake by 32% in Q2 2026, buying an estimated $327K and bringing the position to 706,667 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Vanguard Fiduciary Trust first reported a position in NMRA in Q1 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Vanguard Fiduciary Trust held 706,667 shares of Neumora Therapeutics worth $1.2M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 171,634 Neumora Therapeutics shares in Q2 2026, an estimated $327K.
  • Neumora Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2946 holding.
  • Vanguard Fiduciary Trust first reported a position in Neumora Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.